Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18292776.
- Also identified by DOI 10.1038/nrc2345 and PMC identifier 2484121.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Numerous components and pathways are involved in the complex interplay between cancer cells and their environment. The family of glycophosphoproteins comprising osteopontin, bone sialoprotein, dentin matrix protein 1, dentin sialophosphoprotein and matrix extracellular phosphoglycoprotein - small integrin-binding ligand N-linked glycoproteins (SIBLINGs) - are emerging as important players in many stages of cancer progression. From their detection in various human cancers to the demonstration of their key functional roles during malignant transformation, invasion and metastasis, the SIBLINGs are proteins with potential as diagnostic and prognostic tools, as well as new therapeutic targets.
Medical subject headings
- Extracellular Matrix Proteins
- Gene Expression Regulation, Neoplastic
- Glycoproteins
- Neoplasms
- Phosphoproteins